Kevin M. Ban Net Worth

The estimated Net Worth of Kevin M. Ban is at least $334 Mille dollars as of 18 November 2022. Kevin Ban owns over 10,303 units of Walgreens Boots Alliance Inc stock worth over $334,034 and over the last 2 years Kevin sold WBA stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Kevin Ban WBA stock SEC Form 4 insiders trading

Kevin has made over 1 trades of the Walgreens Boots Alliance Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Kevin exercised 10,303 units of WBA stock worth $350,714 on 18 November 2022.

The largest trade Kevin's ever made was exercising 10,303 units of Walgreens Boots Alliance Inc stock on 18 November 2022 worth over $350,714. On average, Kevin trades about 2,576 units every 0 days since 2022. As of 18 November 2022 Kevin still owns at least 38,219 units of Walgreens Boots Alliance Inc stock.

You can see the complete history of Kevin Ban stock trades at the bottom of the page.

What's Kevin Ban's mailing address?

Kevin's mailing address filed with the SEC is C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD, IL, 60015.

Insiders trading at Walgreens Boots Alliance Inc

Over the last 10 years, insiders at Walgreens Boots Alliance Inc have traded over $1,229,325,076 worth of Walgreens Boots Alliance Inc stock and bought 5,731,774 units worth $405,845,442 . The most active insiders traders include Barry Jana Partners Llc Ros..., John T Standley e Stefano Pessina. On average, Walgreens Boots Alliance Inc executives and independent directors trade stock every 52 days with the average trade being worth of $2,959,469. The most recent stock trade was executed by Inderpal S Bhandari on 11 April 2024, trading 3,000 units of WBA stock currently worth $54,150.

What does Walgreens Boots Alliance Inc do?

walgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he

Complete history of Kevin Ban stock trades at Walgreens Boots Alliance Inc

Walgreens Boots Alliance Inc executives and stock owners

Walgreens Boots Alliance Inc executives and other stock owners filed with the SEC include:

• Stefano Pessina,
  Executive Vice Chairman of the Board, Chief Executive Officer
• Alexander Gourlay,
  Co-Chief Operating Officer
• Ornella Barra,
  Co-Chief Operating Officer
• James Skinner,
  Executive Chairman of the Board
• James Kehoe,
  Global Chief Financial Officer, Executive Vice President
• Rosalind Gates Brewer,
  CEO & Director
• Ornella Barra,
  Chief Operating Officer of International
• James Kehoe,
  Exec. VP & Global CFO
• John T. Standley,
  Exec. VP & Pres of Walgreens
• William Foote,
  Lead Independent Director
• Janice Babiak,
  Independent Director
• David Brailer,
  Independent Director
• Nancy Schlichting,
  Independent Director
• Dominic Murphy,
  Independent Director
• John Lederer,
  Independent Director
• Ginger Graham,
  Independent Director
• Jose Almeida,
  Independent Director
• Stefano Pessina,
  Exec. Chairman
• Pamela Puryear,
  Global Chief Human Resource Officer, Executive Vice President
• Valerie Jarrett,
  Independent Director
• John Standley,
  Executive Vice President, President - Walgreens
• Francesco Tinto,
  Senior Vice President, Global Chief Information Officer
• Heather Dixon,
  Senior Vice President, Chief Accounting Officer, Global Controller
• Marco Pagni,
  Executive Vice President, Chief Administrative Officer, General Counsel
• Aaron C. Radelet,
  Global Chief Communications Officer & Sr. VP
• Danielle Carim Gray,
  Exec. VP & Global Chief Legal Officer
• Gerald Gradwell,
  Sr. VP of Investor Relations
• Manmohan Mahajan,
  Sr. VP, Global Controller & Chief Accounting Officer
• Elizabeth Burger,
  EVP, Global Chief HR Officer
• Kathleen Wilson Thompson,
  EVP and Global Chief HRO
• Leonard D Schaeffer,
  Director
• Barry Jana Partners Llc Ros...,
  
• Ken Murphy,
  EVP & President, Global Brands
• Kimberly R Scardino,
  SVP, Global Controller and CAO
• George Rollo Fairweather,
  EVP and Global CFO
• Simon John Roberts,
  EVP and President, Boots
• Jan Stern Reed,
  SVP, GC and Corp. Sec.
• Acquisitions Holdings Ltd S...,
  10% owner
• Alejandro Silva,
  Director
• Steven A Davis,
  Director
• Thomas J Jr Sabatino,
  EVP, Global CLO and CAO
• Timothy J Theriault,
  EVP and Global CIO
• Timothy R Mclevish,
  EVP and CFO
• Jeffrey Berkowitz,
  Executive Vice President
• Rosalind G Brewer,
  CEO
• Holly May,
  EVP, Global Chief HR Officer
• Danielle Gray,
  EVP and Global CLO
• Inderpal S Bhandari,
  Director
• Steven J Shulman,
  Director
• Kevin M. Ban,
  EVP, Chief Medical Officer
• Henry Lee Cooper,
  EVP, Pres. Walgreens Pharmacy
• John Patrick Driscoll,
  EVP, Pres. U.S. Healthcare
• Richard P. Gates,
  SVP, Chief Pharmacy Officer
• Thomas E Jr Polen,
  Director
• Neal J. Sample,
  EVP, Chief Information Officer
• Bryan C Hanson,
  Director
• Tracey D Brown,
  EVP, Pres., Walgreens Retail
• Timothy C Wentworth,
  Chief Executive Officer
• Robert Luther Huffines,
  Director
• Manmohan Mahajan,
  EVP and Global CFO
• Beth Amber L. Fabbri,
  Chief Corp. Affairs Officer
• Todd Heckman,
  SVP, Global Controller and CAO
• Lanesha Minnix,
  EVP and Global CLO
• Mary Langowksi,
  EVP, President U.S. Healthcare